# FDA Inspection 1274303 - Takeda Pharamaceutical Company Limited - June 06, 2025

Source: https://www.keypedia.com/records/fda_inspections/takeda-pharamaceutical-company-limited/d7a387ed-5276-41d8-894f-77bea6156cd4
Source feed: FDA_Inspections

> FDA Inspection 1274303 for Takeda Pharamaceutical Company Limited on June 06, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1274303
- Company Name: Takeda Pharamaceutical Company Limited
- Inspection Date: 2025-06-06
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Denver District Office

## Related Documents

- [FDA Inspection 1099094 - 2019-07-17](https://www.keypedia.com/records/fda_inspections/takeda-pharamaceutical-company-limited/c2dc0a0b-0042-4b86-831a-04fac0fdf08f)
- [FDA Inspection 1050331 - 2018-04-10](https://www.keypedia.com/records/fda_inspections/takeda-pharamaceutical-company-limited/133a9cc5-8239-42fe-8e7d-c8ff47fdd6ae)

Company: https://www.keypedia.com/companies/takeda-pharamaceutical-company-limited/dd8ea3d2-c1ad-4e50-aadb-1c84da3652fd

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face